H.R.3797 - Medical Marijuana Research Act116th Congress (2019-2020)
|Sponsor:||Rep. Blumenauer, Earl [D-OR-3] (Introduced 07/17/2019)|
|Committees:||House - Energy and Commerce; Judiciary | Senate - Judiciary|
|Committee Reports:||H. Rept. 116-619|
|Latest Action:||Senate - 12/18/2020 Read twice and referred to the Committee on the Judiciary. (All Actions)|
This bill has the status Passed House
Here are the steps for Status of Legislation:
- Passed House
Summary: H.R.3797 — 116th Congress (2019-2020)All Information (Except Text)
Introduced in House (07/17/2019)
Medical Marijuana Research Act of 2019
This bill establishes a new, separate registration process to facilitate medical marijuana research.
Specifically, it directs the Drug Enforcement Administration to register (1) practitioners to conduct medical marijuana research, and (2) manufacturers and distributors to supply marijuana for such research.
Additionally, the Department of Health and Human Services must continue to produce marijuana through the National Institute on Drug Abuse Drug Supply Program and offer to sell immature plants and seeds to researchers until manufacturers and distributors can provide a sufficient supply of marijuana for medical research.